A previous report showed that serum pPE levels were higher in Alzheimer’s disease patients than in age-matched controls [35] and increased Cer and decreased SM levels in plasma were observed in patients with early-stage AD [36]. This evidence concerns the gene CBLN1 and Alzheimer disease.